Catalent, Inc. (CTLT)
After hours:
| Previous close | 60.71 |
| Open | 60.71 |
| Bid | 60.50 x 800 |
| Ask | 60.50 x 1000 |
| Day's range | 60.43 - 60.81 |
| 52-week range | 31.80 - 61.20 |
| Volume | |
| Avg. volume | 1,742,171 |
| Market cap | 10.969B |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Reuters
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
NEW YORK (Reuters) -U.S. Senator Elizabeth Warren has asked antitrust regulators to scrutinize a $16.5 billion deal in which Novo Nordisk's controlling shareholder would acquire contract drug manufacturer Catalent, saying it may give the pharmaceutical company an unlawful advantage in obesity drugs. Novo Holdings, the investment firm that has a controlling interest in Novo Nordisk, signed a $16.5 billion deal to buy Catalent in February to boost supply of Wegovy, Novo's blockbuster GLP-1 injectable weight loss drug. "I am concerned that Novo Nordisk's merger with Catalent will give Novo Nordisk unprecedented visibility into and control over its competitor's production capacity, costs, and business practices, and the ability to preference its own products and obstruct its competitors' use of Catalent to produce GLP-1 drugs," Warren said in the letter.
- Zacks
The Zacks Analyst Blog Highlights AppLovin, Duolingo, Paramount, Twilio and Catalent
AppLovin, Duolingo, Paramount, Twilio and Catalent are included in this Analyst Blog.
- Zacks
More Interest Rate Cuts Ahead: 5 Growth Stocks to Benefit
These fives stocks have strong growth potential for the rest of 2024. These are: APP, DUOL, PARAA, TWLO, CTLT.
